Profile data is unavailable for this security.
About the company
Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble products from a range of materials using microwave technology and a customized hydrocarbon extraction platform. The Company is focused on the formulation, manufacturing and launching of value-added cannabis products. It utilizes a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant. It develops specialty products and ingredients that contain a range of cannabinoid and terpene profiles.
- Revenue in CAD (TTM)3.15m
- Net income in CAD-11.30m
- Incorporated2014
- Employees33.00
- LocationRadient Technologies Inc8223 Roper RoadEDMONTON T6E 6S4CanadaCAN
- Phone+1 (780) 465-1318
- Fax+1 (604) 465-1381
- Websitehttps://www.radientinc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genix Pharmaceuticals Corp | 10.83k | -4.23m | 2.37m | -- | -- | -- | -- | 217.67 | -0.0714 | -0.0714 | 0.0002 | -0.0202 | 0.0049 | 0.0502 | 1.89 | -- | -191.99 | -54.69 | -476.20 | -68.59 | 23.08 | -- | -39,036.01 | -5,345.88 | 0.0541 | -10.33 | -- | -- | -- | -50.60 | -309.27 | -- | -- | -- |
| Intellipharmaceutics International Inc | 1.24m | -4.34m | 2.64m | 33.00 | -- | -- | -- | 2.13 | -0.1311 | -0.1311 | 0.0374 | -0.5319 | 0.6027 | -- | 3.37 | -- | -211.39 | -132.15 | -- | -- | -88.96 | -- | -350.72 | -499.37 | -- | -19.36 | -- | -- | -- | -58.75 | 43.78 | -- | -- | -- |
| Radient Technologies Inc | 3.15m | -11.30m | 2.70m | 33.00 | -- | -- | -- | 0.8548 | -0.0216 | -0.0216 | 0.006 | -0.0278 | 0.1108 | 1.56 | 6.00 | -- | -39.76 | -67.36 | -- | -118.27 | -3.91 | 1.66 | -359.00 | -534.11 | 0.0251 | -3.58 | -- | -- | 45.49 | 65.30 | 69.41 | -- | 200.33 | -- |
| Lifeist Wellness Inc | 21.66m | -14.13m | 2.96m | 72.00 | -- | 0.8063 | -- | 0.1358 | -0.0287 | -0.0287 | 0.0451 | 0.0062 | 1.27 | 3.32 | 7.94 | -- | -82.93 | -62.71 | -158.05 | -78.81 | 30.66 | 17.06 | -65.22 | -136.11 | 0.4707 | -257.62 | 0.268 | -- | -1.85 | -- | 24.45 | -- | -- | -- |
| Hemostemix Inc | 0.00 | -2.50m | 3.05m | -- | -- | -- | -- | -- | -0.0303 | -0.0303 | 0.00 | -0.0846 | 0.00 | -- | -- | -- | -642.29 | -599.98 | -- | -- | -- | -- | -- | -- | -- | -3.99 | -- | -- | -- | -- | 52.21 | -- | -- | -- |
| Entourage Health Corp | 39.46m | -116.92m | 3.07m | 251.00 | -- | -- | -- | 0.0774 | -0.3807 | -0.3807 | 0.1285 | -0.4215 | 0.4954 | 1.79 | 8.08 | -- | -146.79 | -46.15 | -- | -74.68 | 6.12 | -53.10 | -296.29 | -214.31 | 0.0992 | -1.13 | 6.15 | -- | -3.26 | 94.98 | -56.01 | -- | -13.82 | -- |
